NASDAQ:VRTX

Vertex Pharmaceuticals Stock Forecast

etoro logo Buy VRTX
*Your capital is at risk
$523.91
+27.84 (+5.61%)
At Close: Aug 10, 2026

Should you buy VRTX stock?

Last updated:

Based on market data through , StockInvest.us rates Vertex Pharmaceuticals Incorporated (VRTX) as a Buy Candidate with a technical score of 3.48 on its -10 to +10 scale. This is an upgrade from Hold in the previous daily evaluation.

  • Buy signal since
  • Price since signal Flat 0.00%
  • 3-month trend forecast Up 13.81%
  • Buy Candidate 3.48
AI Analysis AI Analysis of VRTX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add VRTX to Watchlist?
Some Reasons Why To Add VRTX:
  • High gross margin of 86.0%
  • Strong operating margin of 38.6%
  • Healthy interest coverage ratio of 738.2x
PDF

On Monday, Vertex Pharmaceuticals Incorporated stock price gained an impressive 5.61%
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Aug 10, 2026

The Vertex Pharmaceuticals Incorporated stock price gained 5.61% on the last trading day (Monday, 10th Aug 2026), rising from $496.07 to $523.91. During the last trading day the stock fluctuated 5.07% from a day low at $519.82 to a day high of $546.17. The price has been going up and down for this period, and there has been a 9.38% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $1.40 billion.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 13.81% during the next 3 months and, with a 90% probability hold a price between $541.92 and $633.72 at the end of this 3-month period.

VRTX Signals & Forecast

The Vertex Pharmaceuticals Incorporated stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $487.91 and $487.92. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, July 06, 2026, and so far it has fallen -1.07%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Vertex Pharmaceuticals Incorporated stock

Vertex Pharmaceuticals Incorporated finds support from accumulated volume at $522.25 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $26.35 between high and low, or 5.07%. For the last week the stock has had daily average volatility of 3.64%.

Our recommended stop-loss: $504.59 (-3.69%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 25 days ago.)

Trading Expectations (VRTX) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Vertex Pharmaceuticals Incorporated to open at $529.97, and during the day (based on 14 day Average True Range), to move between $515.75 and $532.07, which gives a possible trading interval of +/-$16.33 (+/-3.17%) up or down from last closing price. If Vertex Pharmaceuticals Incorporated takes out the full calculated possible swing range there will be an estimated 3.17% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $522.25 (0.32%) than the resistance at $528.04 (0.79%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Vertex Pharmaceuticals Incorporated stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Vertex Pharmaceuticals Incorporated stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 3.477 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $529.97 ( 1.16%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

VRTX Performance

Trading levels for VRTX

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 556.32 6.19%
R2 546.25 4.26%
R1 540.03 3.08%
Price 523.91
S1 519.90 -0.765%
S2 513.68 -1.95%
S3 503.62 -3.87%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 529.59 1.08%
R1 528.04 0.788%
Price 523.91
S1 522.25 -0.317%
S2 491.34 -6.22%
S3 451.63 -13.80%

FAQ

What is the symbol for Vertex Pharmaceuticals Incorporated Stock and on which exchange is it traded?
The symbol for Vertex Pharmaceuticals Incorporated is VRTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Vertex Pharmaceuticals Incorporated Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Vertex Pharmaceuticals Incorporated (VRTX) as a Buy Candidate with a technical score of 3.48 on its -10 to +10 scale. This is an upgrade from Hold in the previous daily evaluation. Since the Buy signal began on Aug 10, 2026, the price has remained flat. The current 3-month trend forecast projects a rise of 13.81%.

How to buy Vertex Pharmaceuticals Incorporated Stock?
Vertex Pharmaceuticals Incorporated Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Vertex Pharmaceuticals Incorporated Stock.

What's the current price of Vertex Pharmaceuticals Incorporated Stock?
As of the end of day on the Aug 10, 2026, the price of an Vertex Pharmaceuticals Incorporated (VRTX) share was $523.91.

What is the 52-week high and low for Vertex Pharmaceuticals Incorporated Stock?
The 52-week high for Vertex Pharmaceuticals Incorporated Stock is $546.17 and the 52-week low is $362.50.

What is the market capitalization of Vertex Pharmaceuticals Incorporated Stock?
As of the Aug 10, 2026, the market capitalization of Vertex Pharmaceuticals Incorporated is 132.971B.

When is the next earnings date for Vertex Pharmaceuticals Incorporated?
The upcoming earnings date for Vertex Pharmaceuticals Incorporated is Nov 02, 2026.
Click to get the best stock tips daily for free!
ABOUT VERTEX PHARMACEUTICALS INCORPORATED
Vertex Pharmaceuticals
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE